poisar

Stock

DexCom, Inc. DXCM

$91.48+0.75%

Overview

DXCM market data

Price History

DXCM price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
32.48
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$2.06
Diluted earnings per share over the trailing twelve months.
Beta
1.48
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
20.1%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$54.11 – $91.04
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $32.5B · P/B 9.43 · P/S 6.53.

Company News

10 captured
Argus Research Maintains Buy on DexCom, Raises Price Target to $96Benzinga · Aug 4, 2026, 2:17 PM
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $90Benzinga · Aug 3, 2026, 9:19 PM
Citigroup Maintains Buy on DexCom, Raises Price Target to $88Benzinga · Jul 31, 2026, 8:21 PM
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $90Benzinga · Jul 31, 2026, 6:49 PM
Mizuho Maintains Outperform on DexCom, Raises Price Target to $95Benzinga · Jul 31, 2026, 5:49 PM
Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 BillionBenzinga · Jul 31, 2026, 5:42 PM
JP Morgan Maintains Neutral on DexCom, Raises Price Target to $82Benzinga · Jul 31, 2026, 5:25 PM
DexCom shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance. Also, multiple analysts raised their respective price targets on the stock.Benzinga · Jul 31, 2026, 2:59 PM
Piper Sandler Reiterates Overweight on DexCom, Raises Price Target to $95Benzinga · Jul 31, 2026, 2:47 PM
Wells Fargo Maintains Overweight on DexCom, Raises Price Target to $90Benzinga · Jul 31, 2026, 2:31 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock